Huons Co. Ltd (243070) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.028x

Based on the latest financial reports, Huons Co. Ltd (243070) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.92 Billion ≈ $7.40 Million USD) by net assets (₩395.25 Billion ≈ $267.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Huons Co. Ltd for the company's overall valuation and market capitalisation.

Huons Co. Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Huons Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Huons Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Huons Co. Ltd ranked by their cash flow conversion efficiency. Explore Huons Co. Ltd cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Kolon Globalco
KO:003070
-0.145x
Amaero Ltd
AU:3DA
-0.190x
Digital Daesung Co. Ltd
KQ:068930
0.099x
Acme United Corporation
NYSE MKT:ACU
-0.019x
Silver Mountain Resources Inc
V:AGMR
-0.044x
Airtel Africa Plc
LSE:AAF
0.286x
PIE Industrial Bhd
KLSE:7095
0.036x
Paragon Care Ltd
AU:PGC
-0.088x

Annual Cash Flow Conversion Efficiency for Huons Co. Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Huons Co. Ltd from 2016 to 2024. View Huons Co. Ltd stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩345.97 Billion
≈ $234.46 Million
₩52.56 Billion
≈ $35.62 Million
0.152x -3.74%
2023-12-31 ₩330.41 Billion
≈ $223.92 Million
₩52.14 Billion
≈ $35.34 Million
0.158x +39.22%
2022-12-31 ₩282.46 Billion
≈ $191.42 Million
₩32.02 Billion
≈ $21.70 Million
0.113x -45.74%
2021-12-31 ₩266.09 Billion
≈ $180.33 Million
₩55.59 Billion
≈ $37.67 Million
0.209x +7.28%
2020-12-31 ₩238.80 Billion
≈ $161.83 Million
₩46.51 Billion
≈ $31.52 Million
0.195x -10.06%
2019-12-31 ₩194.52 Billion
≈ $131.82 Million
₩42.12 Billion
≈ $28.54 Million
0.217x +69.29%
2018-12-31 ₩163.27 Billion
≈ $110.64 Million
₩20.88 Billion
≈ $14.15 Million
0.128x -48.05%
2017-12-31 ₩122.69 Billion
≈ $83.15 Million
₩30.21 Billion
≈ $20.47 Million
0.246x -46.72%
2016-12-31 ₩93.88 Billion
≈ $63.62 Million
₩43.38 Billion
≈ $29.40 Million
0.462x --

About Huons Co. Ltd

KQ:243070 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$158.32 Million
₩233.62 Billion KRW
Market Cap Rank
#17531 Global
#715 in Korea
Share Price
₩20050.00
Change (1 day)
-0.50%
52-Week Range
₩20000.00 - ₩38200.00
All Time High
₩66595.39
About

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, anti-coagulant, antiviral, central nervous system, antibiotic, well-being, urogenital system, and other ch… Read more